Viz.ai, the developer of a system that applies artificial intelligence technology to the healthcare process, has raised $21m in a series A round featuring internet and technology group Alphabet.
Alphabet participated through its GV subsidiary and was joined by venture capital firm Kleiner Perkins Caufield & Byers. The round came after a $7.5m seed round co-led by DHVC and Innovation Endeavors in May 2017 that included AME Cloud Ventures.
Founded in 2016, Viz has developed software capable of detecting and triaging urgent stroke cases by detecting large vessel occlusions in brain scans and sending the scans to a neurovascular specialist who can make sure the stroke is treated quickly.
The funding will be used to extend the technology to other conditions besides strokes. Chris Mansi, co-founder and CEO of Viz, said: “In stroke every minute matters. Our goal is to fundamentally change healthcare, making it proactive rather than reactive.
“By integrating Viz, we believe healthcare systems can increase access to proven life-saving therapy and reduce the time to treatment across their referral network. AI-assisted triage has the potential to save lives and reduce disability. We are delighted to partner with top tier investors at Kleiner Perkins and GV.”